跳至主要内容
临床试验/NCT04032002
NCT04032002已完成不适用

Involvement of Monocytic B1 and B2 Receptors in Inflammation and Chronic Vascular Disease in Patients With Hereditary Bradykinetic Angioedema

University Hospital, Rouen1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2020年11月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
compare the gene expression of B1 and / or B2 monocyte receptors

研究概览

简要总结

The objective is to compare the gene expression of B1 and / or B2 monocyte receptors between patients with hereditary bradykinetic angioedema and control subjects.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • (patients):
  • Patient with inherited bradykinic angioedema due to quantitative or qualitative C1-inhibitor deficiencies, regardless of the frequency or severity of seizures and regardless of their background treatment, with the following diagnostic criteria:
  • C1-inhibitor rate <50% of normal
  • Repeated episodes characteristic of bradykinic angioedema
  • Hereditary nature of the disease.
  • Person who read and understood the newsletter and signed the consent form
  • Person affiliated with a social security scheme
  • Effective contraception in women of childbearing age (negative pregnancy test). For postmenopausal women, a confirmatory diagnosis should be obtained (amenorrhea for at least 12 months before the inclusion visit).
  • Inclusion Criteria (volunteers):
  • Person affiliated with a social security scheme
  • Person who read and understood the newsletter and signed the consent form
  • Effective contraception in women of childbearing age (negative pregnancy test). For postmenopausal women, a confirmation diagnosis should be obtained (amenorrhea for at least 12 months before the inclusion visit)

排除标准

  • (patients):
  • Angioedema crisis less than 1 month old
  • Chronic inflammatory disease such as rheumatoid arthritis or Crohn's disease.
  • Acute infection in progress, with or without anti-infectious treatment
  • Contraindication to the use of trinitrin:
  • Hypersensitivity to nitrates or to any of the excipients
  • shock, severe hypotension,
  • obstructive cardiomyopathy,
  • inferior court inferior myocardial infarction with right ventricular extension, except in case of evidence of left ventricular failure,
  • intracranial hypertension,
  • patient treated with sildenafil
  • Pregnant or parturient or breastfeeding woman or lack of proven contraception
  • Person deprived of liberty by an administrative or judicial decision or person placed under the protection of justice / sub-tutorship or curatorship
  • Patient participating or having participated in another therapeutic trial within one week.
  • Exclusion Criteria (volunteers)
  • Chronic inflammatory disease such as rheumatoid arthritis or Crohn's disease.
  • Acute infection in progress, with or without anti-infectious treatment
  • Contraindication to the use of trinitrin:
  • Hypersensitivity to nitrates or to any of the excipients
  • shock, severe hypotension,
  • obstructive cardiomyopathy,
  • inferior court inferior myocardial infarction with right ventricular extension, except in case of evidence of left ventricular failure,
  • intracranial hypertension,
  • patient treated with sildenafil
  • Pregnant or parturient or breastfeeding woman or lack of proven contraception
  • Person deprived of liberty by an administrative or judicial decision or person placed under the protection of justice / sub-tutorship or curatorship
  • Person participating or having participated in another therapeutic trial within one week.

研究组 & 干预措施

Patients hereditary bradykinetic angioedema

Other

干预措施: Explorations (Other)

Patients hereditary bradykinetic angioedema

Other

干预措施: Blood samples (Other)

healthy volunteers

Other

干预措施: Explorations (Other)

healthy volunteers

Other

干预措施: Blood samples (Other)

结局指标

主要结局

compare the gene expression of B1 and / or B2 monocyte receptors

时间窗: Day 1

compare between patients with hereditary bradykinetic angioedema and control subjects.

次要结局

未报告次要终点

研究者

发起方
University Hospital, Rouen
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验